OrbiMed’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160M | Hold |
|
|||||
|
2025
Q1 | $157M | Hold |
|
|||||
|
2024
Q4 | $179M | Hold |
|
|||||
|
2024
Q3 | $203M | Hold |
|
|||||
|
2024
Q2 | $186M | Sell |
|
|||||
|
2024
Q1 | $158M | Hold |
|
|||||
|
2023
Q4 | $125M | Hold |
|
|||||
|
2023
Q3 | $123M | Hold |
|
|||||
|
2023
Q2 | $184M | Buy |
|
|||||
|
2023
Q1 | $197M | Buy |
|
|||||
|
2022
Q4 | $17.9M | Hold |
|
|||||
|
2022
Q3 | $10K | Hold |
|
|||||
|
2022
Q2 | $5.35K | Hold |
|
|||||
|
2022
Q1 | $8.25M | Hold |
|
|||||
|
2021
Q4 | $9.87M | Hold |
|
|||||
|
2021
Q3 | $17.9M | Buy |
|
|||||
|
2021
Q2 | $21.5M | Hold |
|
|||||
|
2021
Q1 | $23M | Hold |
|
|||||
|
2020
Q4 | $60M | Hold |
|
|||||
|
2020
Q3 | $55.3M | Hold |
|
|||||
|
2020
Q2 | $75.2M | Hold |
|
|||||
|
2020
Q1 | $43.6M | Buy |
|